Abstract Interferon (IFN)-α2 is an extensively therapeutically used pro-inflammatory cytokine. Though its efficacy in controlling viral replication and tumor cells proliferation, administration of IFN-α2 is often associated with the development of central side effects. Magnetic resonance spectroscopy studies have demonstrated that IFN-α2 administration affects brain metabolism, however the exact nature of this effect is not completely known. We hypothesized that IFN-α2 can affect metabolic activity of human neuron-like SH-SY5Y cells which possess many characteristics of neurons and represent one of the most used models for studying mechanisms involved in neurotoxicity or neuroprotection. To test our hypothesis we have characterized the metabolic signature of live SH-SY5Y, and their conditioned media, after 24 and 72 h of exposure to vehicle or IFN-α2 (100 ng/ml) by using High Resolution-Magic Angle Spinning (HR-MAS) Nuclear Magnetic Resonance (NMR) spectroscopy. Our results revealed that 1) the use of HR-MAS NMR is ideally suitable for the characterization of the metabolic profile of live cells and their conditioned media without extraction procedures; and 2) a 72 h exposure to IFN-α2 increases the level of metabolites involved in maintaining energetic (including creatine and lactate) and osmotic (such as myo-inositol, scyllo-inositol, taurine and glycerophosphorylcholine) balances in neuron-like cells and of metabolic waste products (namely lactate, ethanol and acetate), glycine and glutamine in their growth media. These results may contribute to gain more knowledge about the IFN-α2 induced effect on the brain and support the interpretation of magnetic resonance spectroscopy studies performed in humans.
Introduction
Interferon (IFN)-α2 is an innate immune cytokine with potent antiviral and anti-proliferative properties that is extensively used to treat highly prevalent medical conditions such as viral infections (i.e. hepatitis C) and tumors. However, despite therapeutic efficacy in these illnesses, it has been observed that IFN-α2 therapy is associated with neuroinflammation, neurodegeneration and with the development of psychiatric side-effects (Alboni et al. 2013; Hofer and Campbell 2013; Leutscher et al. 2010; Paul et al. 2007; Spennati and Pariante 2013; Taylor et al. 2014) . In order to develop therapeutic strategies aimed at counteracting IFN-α2-induced effects on the nervous system, without interfering with the efficacy of the antiviral treatment, molecular effects on brain cells triggered by exposure to the cytokines (including neurons) have to be fully characterized.
It is now widely accepted that cortical and subcortical brain regions, and neurons, represent important targets of IFN-α, as also demonstrated by brain imaging techniques (Capuron et al. 2005 (Capuron et al. , 2012 Daducci et al. 2014; Wada et al. 2006) . Indeed, neurons can be both type I IFN producers and IFN responding cells (Paul et al. 2007 ). To deepen our knowledge of the molecular effects triggered by IFN-α2 in these cells, given the ethical and experimental issues associated with the use of human brains, investigation has to shift to in vitro studies. Even though limitations also exist in the use of in vitro models in the field of neuroscience (mainly the phenotypic instability of immortalized cell lines and the loss of specific cell type interaction and of system complexity), these in vitro models offer important advantages including the possibility to operate in a controlled environment and to obtain valuable insight into critical cell type contribution in a specific phenomenon.
Given this in mind, we recently demonstrated that human neuron-like SH-SY5Y cells are responsive to IFN-α2. Exposure to IFN-α2 induces cytotoxic effects in these cells in a time and dose dependent manner. Indeed, a range of IFN-α2 doses (from 2 to 100 ng/ml) reduces the cell density starting from 72 h of exposure (no effect is observed after 24 or 48 h). Given this, we hypothesized that cytotoxic effects induced by IFN-α2 are triggered by the binding of the cytokine to its receptor but require downstream events including reactive oxygen species (ROS) production (Alboni et al. 2013) .
SH-SY5Y cell line is a human catecholaminergic neuroblastoma derived from the SK-N-SH cell line by successive sub-cloning (Biedler et al. 1973) . The human origin and the neuronal properties make the SH-SY5Y cell system a unique tool to study stimulus-induced neurodegenerative conditions both at the molecular and the morphological level. Also given the extensive use of the human neuroblastoma SH-SY5Y cell line as a well-established in vitro cellular model to study the biological consequences of neuroactive molecules, a comprehensive analysis of its transcriptome and proteome have been performed (Calligaris et al. 2009; Gilany et al. 2008) , whereas less is known about its metabolome (Baykal et al. 2008) .
Nuclear Magnetic Resonance (NMR) spectroscopy is recognized as strategic analytical technique to characterize the metabolic profile of biological fluids as well as tissues and cells of human, animal or vegetable origins (Beckonert et al. 2010; Dona et al. 2014; Mucci et al. 2013; Righi et al. 2014; Sitter et al. 2010; Wong et al. 2014) . In particular, High Resolution-Magic Angle Spinning (HR-MAS) NMR is a rapid and non-destructive technique useful to analyze metabolites involved in crucial metabolic pathways and to provide highprecision fingerprints of metabolites in whole cells (Blaise et al. 2007; Righi et al. 2013 ). This non-destructive approach, together with the simplicity of preparation and the small sample quantities required and data acquisition provides advantages over other methods that need chemical treatment protocols to extract metabolites, such as mass spectrometry. Even though its utility, there are only few studies on whole cells: on marine unicellular microalgae cells (Arnold et al. 2015) , bacterial cells (Gudlavalleti et al. 2006; Himmelreich et al. 2003) , and yeast (Palomino-Schätzlein et al. 2013; Righi et al. 2011) . In our study, 1 H High Resolution Magic Angle Spinning (HR-MAS) NMR was used to characterize metabolic signature of living SH-SY5Y cells and to assess changes in metabolic signature of human neuronal cells following exposure to IFN-α2. We performed NMR experiments on cells and their medium at two different times 24 h and 72 h after exposure to IFN-α2.
Method Cell Culture and Experimental Protocol Cell Sampling for HR-MAS NMR
At the end of the exposure time, 1.5 mL of culture supernatants were collected and the cells were washed twice with 5 mL of ice-cold PBS to remove medium residues. Cells were then gently scraped after adding 500 μL of PSB, counted and centrifuged at 3000 × g for 5 min at 4°C. The pellets of cells were immediately processed for HR-MAS experiments. The collected culture supernatants (see above) were centrifuged at 3000 × g for 10 min at 4°C to remove cell debris and supernatants stored at −80°C until HR-MAS analyses. Three mL of the growth medium (M) were placed in a 60 × 15 mm Petri Human neuroblastoma SH-SY5Y cells were grown and maintained in growth medium [Dulbecco's Modified Eagle's Medium (DMEM) High Glucose medium: Ham's nutrients mixture F-12 (1:1) containing 2 mM L-glutamine, 1 % non-essential amino acids, 100 U/mL penicillin and 10 μg/ mL streptomycin, and supplemented with 10 % of US origin fetal bovine serum (FBS)], at 37°C in a humidified atmosphere of 5 % CO 2 in air. Only cells at passages P28 and P29 were used. For the experiments, seven (3 for the 24 h point and 4 for the 72 h point) independent (about 60 % confluent) cultures were harvested and seeded (2.3 ×10 4 and 4 × 10 6 cells for control and 24 h IFN-α2 groups or 72 h IFN-α2 group respectively) into tissue culture dishes (100 × 20 mm) and maintained 24 h before the treatments in growth medium. One day after seeding cells were exposed to either recombinant human IFN-α2 (PeproTech) (100 ng/ml corresponding to at least 18 UI/μL) (N = 6 for 24 h experiments; N = 5 for 72 h experiments) or an equal amount of vehicle [sterile phosphate buffered saline (PBS)] (N = 6 for 24 h experiments; N = 5 for 72 h experiments) in fresh growth medium and incubated for a further 24 or 72 h at 37°C. dish without cells for 24 or 72 h at 37°C in a humidified atmosphere of 5 % CO 2 in air and then collected for HR-MAS analyses. To demonstrate the absence of interferences due to IFN-α2 in the metabolic profile of the culture medium, another sample M added of 100 ng/mL of IFN-α2 was treated as above and analyzed. For 2D 1 H-1 H-COrrelation SpectroscopY (COSY) experiments SH-SY5Y cells (5x10 6 ) were plated in a 100 × 20 mm tissues culture dish in growth medium and collected three days after as previously described.
HR-MAS Experiments
Cells were introduced in a 50 μl MAS zirconia rotor (4 mm OD) with 10 μl of deuterated water (D 2 O), closed with a cylindrical insert to increase sample homogeneity, then transferred into the probe cooled to 5°C. 1 H and 13 C HR-MAS NMR spectra were recorded with a Bruker Avance400 spectrometer operating at 400.13 and 100.61 MHz, respectively. The instrument was equipped with a 1 H,
13
C HR-MAS probe, which temperature was controlled by a Bruker Cooling Unit. The whole experiments were performed at 5°C to prevent cell degradation processes (Righi et al. 2007 ). Samples were spun at 4000 Hz. After the set up (about 20 min), three different types of one-dimensional (1D) proton spectra were acquired by using: i) a composite pulse sequence (zgcppr) (Price et al. 1999) , with 2.5 s water-presaturation during relaxation delay, 8 kHz spectral width, 32 k data points, 64 scans; ii) a watersuppressed spin-echo Carr-Purcell-Meiboom-Gill (CPMG) sequence (cpmgpr) (Meiboom and Gill 1958) , with 1.5 s water presaturation during relaxation delay, 1 ms echo time (τ), and 360 ms total spin-spin relaxation delay (2nτ), 8 kHz spectral width, 32 k data points, 128 scans; and iii) a sequence for diffusion measurements based on stimulated echo and bipolar-gradient pulses (ledbpgp2s1d) (Wu et al. 1995) with big delta 200 ms, eddy current delay T e 5 ms, little delta 2*2 ms, sine-shaped gradient with 32 G/cm followed by a 200 μs delay for gradient recovery, 8 kHz spectral width, 8 k data points, 256 scans. Two-dimensional (2D) COSY spectra were acquired using a standard pulse sequence (cosygpprqf) and 0.5 s water presaturation during relaxation delay, 8 kHz spectral width, 4 k data points, 32 scans per increment, 256 increments. 2D 1 H, 1 H-TOtal Correlation SpectroscopY (TOCSY) spectra (Bax and Davis 1985; Braunschweiler and Ernst 1983) were acquired using a standard pulse sequence (mlevphpr) and 0.5 s water-presaturation during relaxation delay, 100 ms mixing (spin-lock) time, 4 kHz spectral width, 4 k data points, 32 scans per increment, 128 increments. 2D 1 H, 13 C-heteronuclear single quantum coherence (HSQC) (Bodenhausen and Ruben 1980) spectra were acquired using an echo-antiecho phase-sensitive standard pulse sequence (hsqcetgp) and 0.5 s relaxation delay, 1.725 ms evolution time, 4 kHz spectral width in f2, 4 k data points, 128 scans per increment, 17 kHz spectral width in f1, 256 increments.
Data Processing, Bioinformatics, and Statistical Analysis
Areas of selected peaks of significant metabolites were estimated in CPMG spectra using Mnova software (MestReNova, ver. 8.1.0, 2012 Mestrelab Research S. L., Santiago de Compostela, Spain), with an automated fitting routine based on the Levenberg-Marquardt algorithm applied after manual peak selection, adjusting peak positions, intensities, line widths and Lorentzian/Gaussian ratios, until the residual spectrum was minimized (Swanson et al. 2006 ). Here we defined relative concentration as the ratio of the relative resonance area of all the quantifiable metabolites (calculated by measuring the area of individual metabolites signal divided for their proton number) and the respective cells number. Data were reported as means ± standard errors (arbitrary units). Statistical analyses were performed using MetaboAnalyst 2.0 -a comprehensive server for metabolomic data analysis (Xia et al. 2009 (Xia et al. , 2012 . For Student's t-test, paired two-sample test was used to determine the means. P < 0.05 was considered to indicate a statistically significant difference. Receiver Operating Characteristic Curve Explorer & Tester (ROCCET) (http://www.roccet.ca/ROCCET) (Xia et al. 2012 ) software was applied on selected integrals in order to build a classification model. Differentially abundant metabolites between untreated and IFN-α-treated cells (and relative conditioned media) were mapped in the Kyoto Encyclopedia of Genes and Genomics (KEGG) database (human metabolic network) and related software applications (http://www. genome.jp/kegg/) (Kanehisa and Goto 2000) .
Results

Assessment of HR-MAS NMR Metabolic Profiles of Intact SH-SY5Y Cells and Their Growth Media
Although human SH-SY5Y cell line has been extensively used in neuroscience research, the metabolic profile of these cells is still poorly characterized (Baykal et al. 2008) . Through HR-MAS NMR 1D and 2D experiments, we assessed the metabolome of living SH-SY5Y control cells. Figure 1a shows a representative 1 H HR-MAS NMR spectrum acquired on human neuronal SH-SY5Y control cells (C Ctrl ). The spectrum provides a direct identification of several metabolites such as alanine (Ala), acetate (Ac), creatine (Cr), glutathione (GSH), glycine (Gly), myo-inositol (Myo), lactate ( L a c ) , t a u r i n e ( T a u ) , f r e e c h o l i n e ( C h o ) , glycerophosphocholine (GPC), phosphocholine (PC), uridine monophosphate (UMP) and adenine. The broad peaks at 0.89, 1.33, 1.58, 2.03, 2.24 and 5.20 ppm are due to fatty acyl chain signals, related to the N(CH 3 ) 3 + head group of phospholipids (PL) at 3.26 ppm. Moreover, close to these signals macromolecules of peptidic nature are also present (MM). For a complete metabolic assignment we performed different 2D NMR experiments: COSY, TOCSY and HSQC. After the analysis, we were able to identify several metabolites which resonances are overlapped in the 1D spectrum. From 2D experiments (see supplementary Fig. 1Sa ) other important metabolites were identified: glutamate (Glu), proline (Pro), phosphoethanolamine (PE), hypotaurine (Hypo), methionine (Met), threonine (Thr), malic acid (MA), lysine (Lys), citrate (Cit), leucine (Leu), isoleucine (Ile) and valine (Val).
The identified metabolites (supplementary Table 1S ) are mainly amino acids (39 %), organic acids (22 %), osmolytes (12 %), sugars and polyols (10 %), nucleotide derivatives (10 %) and other miscellaneous metabolites (7 %).
The same 1D and 2D NMR experiments were performed on SH-SY5Y after a 72 h exposure to recombinant IFN-α2 (100 ng/mL) (C ) and the same metabolites were assigned. Figure 1b shows 1D spectrum of SH-SY5Y cells after a 72 h exposure to IFN-α2. The metabolic profile was similar to that of control cells. In order to highlight significant changes, more detailed chemometric and quantitative analyses were performed (see below).
Besides the complete characterization of cell's metabolome, we analyzed their growth media, before (M) and after cell cultures (M Ctrl and M IFN-α2 ), to evidence differences in catabolites for control and IFN-α2-treated cells. First, we characterized the growth medium that was incubated for 72 h at 37°C in a humidified atmosphere of 5 % CO 2 in air without cells (Fig. 2a) (M) . We also controlled the 1 H NMR spectrum of growth medium added with 100 ng/mL of human recombinant IFN-α2, and no changes were observed with respect to free medium without the cytokine (data not shown).
As expected growth medium was composed in major part of glucose (α-and β-glucose, α-and β-Glc) used as nutrient for the cells to grow, together with aliphatic aminoacids (Ile, Val, Leu, Ala), Lys, Gln and aromatic aminoacids (phenylalaninePhe and tyrosine -Tyr). We can observe a singlet at 2.37 ppm, characteristic of pyruvate (Pyr), and signals due to Lac, ethanol (EtOH), Ac and Cho. Figure 2b and c report composition of the medium where control and treated cells were grown, Major metabolites are labeled: acetate (Ac), alanine (Ala), ethanol (EtOH), formiate (F), α-and β-glucose (α-and β-Glc), glutamine (Gln), isoleucine (Ile), lactate (Lac), leucine (Leu), lysine (Lys), phenylalanine (Phe), pyruvate (Pyr), succinate (Suc), tyrosine (Tyr), valine (Val) respectively (see also supplemetary Fig. 1Sb for 2D COSY spectrum of control cells). At a glance, an important reduction of Glc and of some aminoacids (e.g. Gln, Phe, Tyr, Val, Ile, Leu) and an increase of Lac, EtOH and Suc in the growth medium of IFN-α-treated cells (M IFN-α2 ), with respect to that of SH-SY5Y control cells (M Ctrl ), was appreciated ( Fig. 2b  and c) .
Chemometric and Quantitative Approaches in the Assessment of Metabolic Changes in SH-SY5Y Cells Induced by a 24 h and 72 h IFN-α2 Exposure For a fine metabolic evaluation of the effects induced by IFN-α2 exposure on SH-SY5Y cells and on their growth medium, two major approaches, chemometric and quantitative, were used. The chemometric approach was applied on 1D 1 H CPMG spectra to identify relevant spectral features that permit to distinguish sample classes. For the chemometric analysis we used the two most common methods: Principal Component Analysis (PCA) and Partial-Least Squares Discriminant Analysis (PLS-DA). PCA is an unsupervised method aimed at finding the directions of maximum variance in a data set (X) without referring to the class labels (Y), whereas PLS-DA is a supervised method that uses multiple linear regression technique to find the directions of maximum covariance between a data set (X) and the class membership (Y) (Xia et al. 2012) . PCA was applied to the spectra set of control cells vs IFN-α2-treated cells to visualize homogeneity of each group and eventually exclude outliers. PLS-DA was used to build a model for sample classification. We performed the chemometric analysis on control vs IFN-α2 24 h and 72 h treated cells. At 24 h time exposure, we did not observe in PCA and PLS-DA analysis any qualitative change between control vs IFN-α2 treated cells (supplementary Fig. 2Sa and 2Sb) . Figure 3a and b report PCA and PLS-DA scores plots of control vs 72 h IFN-α2-treated cells. The PC1 accounts for 98.4 % of the total variance in PCA analysis (supplementary Fig. 3Sa ), but does not help in the discrimination of the two classes, whereas the principal component that seems to better describe the variations between the two groups of spectra is PC5, as can be observed in PC2 vs PC5 scores plot reported in Fig. 3a .
The PC5 loadings (supplementary Fig. 4Sa ) profile seems to indicate that Lac, GPC and Cr can be the metabolites that discriminate control (C Ctrl ) vs IFN-α2-treated (C IFN-α2 ) cells. PLS-DA analysis, reported in Fig. 3b , shows a good discrimination for control vs IFN-α-treated cells along the LV2 (second latent variable) direction (4.2 % total variance). Figure 3c and d report the same analysis, PCA and PLS-DA, for medium from control and 72 h IFN-α-treated cells. The two groups cluster in a very good way in both analysis. A good discrimination can be observed in PC1 vs PC2 scores plot (Fig. 3c) . The PC1 and PC2 loadings (supplementary Fig. 4Sb ) profiles show that Lac, EtOH, Ala, Ac, Gly and Cr represent metabolites that discriminate culture media from vehicle exposed cells (M Ctrl ) vs culture media from IFN-α2-treated cells (M ). The same for PLS-DA analysis where LV1 vs LV2 scores plot shows a good discrimination clustering, Fig. 3d , for control vs IFN-α treated cells. Chemometric analysis for conditioned medium from cells treated with IFN-α2 (M IFN-α2 ) or vehicle (M Ctrl ) for 24 h did not show any qualitative change between control vs treated cells in PCA and PLS-DA analysis (supplementary Fig. 5S ).
Chemometric approach points to some interesting metabolites for the distinction of Ctrl and 72 h IFN-α2-treated cells, and these data were combined with data coming from quantitative analysis.
Selected signals (those less overlapped) of different metabolites (F, U, Asc, Lac, Myo, Gly, Tau, Scy, GPC, PC, Cho, Cr, Suc, Pyr, Glu, Ac, Ala) were integrated in the ex vivo 1D HR-MAS 1 H CPMG spectra of the two groups of cells, and a t-test was run.
lactate were significantly higher in the IFN-α2-treated cells (C IFN-α2 ) compared to control cells (C Ctrl ) (p = 0.0009; p = 0.03; p = 0.02; p = 0.005; p = 0.03 and p = 0.01, respectively). Free choline level was higher, even if it did not reach statistical significance (p = 0.06), in intact cells exposed to IFN-α2 for 72 h (C IFN-α2 ) than in control cells (C Ctrl ). Data are reported in Table 1 .
On the other hand, the quantitative data from intact cells exposed to IFN-α2 for 24 h (C IFN-α2 ) compared to their control cells (C Ctrl ) did not show any statistical significant data, confirming the PCA results.
To verify these results and those of multivariate analyses, integrated areas of the previously selected signals where compared and a ROC analysis (Xia et al. 2012 ) was undertaken. ROC analysis of integrals confirmed that the more promising metabolites for a classification of IFN-α2-treated cells vs control cells (C Ctrl ) were GPC, Tau and Lac, being their area under ROC curves (AUC) above 0.8 (Xia et al. 2012) . Also others metabolites, such as Myo, Cho and Cr, seem to be promising for the classification of the two cell groups (Fig. 4,  supplementary Fig. 6S ).
The same quantitative approach employed for cell samples was applied to the spectra of the medium samples. The analysis shows that the levels of lactate, ethanol, acetate, glutamine and glycine were different between the medium samples derived from control cells (M Ctrl ) and from IFN-α-treated cells (M IFN-α2 ) (p = 0.009; p = 0.03; p = 0.01; p = 0.014 and p = 0.02 respectively). Statistical analysis shows a tendency towards an increase (p = 0.0499) in the level of alanine in the M Ctrl with respect to M (Table 2) . 146 J Neuroimmune Pharmacol (2016) 11:142-152 Statistical analysis showed that the levels of taurine, myo--inositol, scyllo-inositol, glycerophosphocholine, creatine and ROC analysis of integrals of the selected metabolites confirmed that those more promising for a classification of media samples derived from cultures of SH-SY5Y cells either untreated or treated for 72 h with 100 ng/mL of IFN-α2 were Lac, Ac, EtOH and Gly since the area under ROC curves (AUC) is above 0.8 (Xia et al. 2012) . Based on ROC analyses, others metabolites such as Gln, Pyr and Ala, can be also considered for the classification of the two culture medium groups (Fig. 5, supplementary Fig. 7S ).
Discussion
The central side-effects associated with immune therapy with pro-inflammatory cytokines, including interferons α, strongly prompt the research in this field aimed at: 1) developing therapeutic strategies to prevent undesirable cytokine-induced effects and 2) improving our knowledge about the role of inflammation in the etiopathogenesis of neurodegenerative and psychiatric diseases. Mechanistic questions have to be addressed to achieve these aims.
Proliferating or differentiated SH-SY5Y cells are a human cellular model extensively used to explore molecular effects of neuroactive compounds (Alboni et al. 2013; Dias et al. 2014; Titze-de-Almeida et al. 2014; Wang et al. 2014) as well as to study mechanisms underlying neurodegenerative diseases in humans (Chiu et al. 2015; Feng et al. 2014; Pimenova et al. 2014; Zheng et al. 2013) . Here, to our knowledge, we characterized for the first time, through HR-MAS NMR analysis, the metabolic fingerprint of intact human neuronal SH-SY5Y cells and their culture medium. Metabolites with an important role in the central nervous system functionality have been identified (Maddock and Buonocore 2012) .
We were then able to demonstrate that while a 24 h exposure to IFN-α2 does not change metabolic signature of SH-SY5Y cells and culture media, a 72 h exposure to the cytokine is associated with metabolic changes both in the cells and their culture media map to pathways associated with second messenger systems, energy metabolism, sugar and lipid metabolism, membrane stabilization and integrity, metabolic waste, oxidative stress and inflammation (supplementary Fig. 6S ). Indeed, PCA and PLS-DA discriminant analyses revealed a clear separation between 72 h IFN-α2 exposed cells or media and respective controls. In general, long-term exposure to IFN-α2 raised the metabolic activity of SH-SY5Y cells as demonstrated by increased concentration of catabolic products (including lactate, ethanol and acetate) in the conditioned media from IFN-α2-exposed cells with respect to control cells. Given that after 72 h exposure to IFN-α2 about 50 % of the cells are dead and about 50 % of the remaining cells are in the early stage of apoptosis, most likely the metabolic waste products are produced by dying cells. We also found increased levels of glycine in the medium, probably due to a reduced cell utilization of the Gly present in the medium components.
In vivo studies have suggested that IFN-α2 induces metabolic changes in the brain, thus contributing to regulate neuronal activity. In particular magnetic resonance spectroscopy (MRS) studies suggested, even with contrasting data, that IFN-α2 treatment is associated with changes in glutamatergic metabolism (Daducci et al. 2014; Haroon et al. 2014; Taylor et al. 2014) . Increased ΔGlu\Cr ratio [(Glu\Cr after about one month of IFN-α2 treatment) -(Glu\Cr at the baseline)] has been demonstrated in the dorsal anterior cingulate cortex (ACC) and left basal ganglia of IFN-α2-treated patients (Haroon et al. 2014) . We found that, in SH-SY5Y cells with a neuronal phenotype, IFN-α2 exposure tends to increase Glu (53 %). However, it has been demonstrated that glutamate release is increased by immune stimuli (i.e. lipopolysaccharide and inflammatory cytokines) from activated microglia (El Ghazi et al. 2010; Yawata et al. 2008) or astrocyte (Jourdain et al. 2007 ). Taylor and coworkers failed to demonstrate glutamate changes in the pregenual ACC in hepatitis C virusinfected patients undergoing IFN-α2 therapy using MRS while they found increased cortical levels of glutamine (Gln \Cr ratio) which correlate with severity of depression and anxiety (Taylor et al. 2014) . Here, we demonstrated increased levels of glutamine in the conditioned media of SH-SY5Y cells exposed to IFN-α2, but not in the cells, suggesting that NMR spectral values are calculated as mean ± SE, Δ% indicated in % the difference of the total integral between C Ctrl and C IFN-α2 . * p < 0.05; ** p ≤ 0.01; *** p < 0.001. Percent differences between treated and control cells. Unpaired one-tailed Student's t-test was used for the comparisons Gln increase depends on a reduced Gln utilization from cells. Indeed, IFN-α2 significantly decreases cell number following a 72 h exposure (Alboni et al. 2013) . Furthermore, we also demonstrated increased levels of Cr in IFN-α2-exposed SH-SY5Y cells. Though this effect was not observed in MRS analysis of the ACC of IFN-α2-treated patients, changes in Cr levels have been described in different neuro-pathological conditions (Caramanos et al. 2005; Chang et al. 2013 ). This is not surprising considering that Cr plays essential roles in the CNS by: i) participating in maintaining energetic homeostasis (Andres et al. 2008) , ii) stabilizing the mitochondrial membrane pores (Dolder et al. 2003) , iii) suppressing free radical (i.e. ROS) formation within mitochondria (Meyer et al. 2006 ) and iv) acting as neuromodulator (Almeida et al. 2006; Royes et al. 2008) . Given this, alteration in total Cr measured by in vivo MRS is indicative of impaired functionality or integrity of the brain parenchyma and care must be taken when the levels of the metabolite are expressed as ratio of total Cr (Cr plus phosphocreatine) (Lei et al. 2009; Rudkin and Arnold 1999) . In SH-SY5Y cells exposed to IFN-α2, as for Cr, we also found increased levels of another metabolite involved in neuronal metabolism such as Lactate. While Lac was longer considered a Bdead-end^metabolite produced only under anaerobic condition like hypoxia, it is now recognized that Lac is an important intermediate in the energy metabolism of neurons and a mediator of redox state (Gladden 2004) . Increased levels of Lac have been found during neuronal activation, subclinical inflammation and impaired oxidative metabolism (Maddock and Buonocore 2012) . Following IFN-α2 exposure, in addition to increased cellular levels of metabolites mainly involved in maintaining energetic homeostasis, we also demonstrated increased levels of metabolites known as main actors in maintaining osmotic homeostasis. In the CNS changes in extracellular fluid osmolality can cause severe neurological symptoms by impairing electrolyte concentration and neuronal excitability (Bourque 2008; Matthews et al. 1997; Simon and Freedman 1980) . Previous studies have shown that in SH-SY5Y cells hyper-osmotic stress may induce apoptosis (Matthews et al. 1997; Stoothoff and Johnson 2001) while conditions of hypo-osmolarity induce Tau and Myo efflux that is enhanced by activation of muscarinic cholinergic receptors (mAChRs) (Loveday et al. 2003) . It has been demonstrated that activation of mAChRs on SH-SY5Y cells provides protection from the apoptotic-signaling cascade induced by DNA damage, oxidative stress and impaired mitochondrial function through a mechanism that remains to be fully determined (De Sarno et al. 2003) . Release of organic osmolytes enhanced by stimulation of mAChRs may represent a protective cellular mechanism to regulate neuron cellular volume, and maintain cell integrity, under hypo-osmotic conditions. Indeed, efflux of osmolytes out of the cells during hypotonic stress is important for preserving cell volume without altering cell function. The changes detected in the intracellular concentration of osmolytes may account for the alterations in cell morphology we observed after 72 h of exposure to the cytokine (supplementary Fig. 9S ). Most osmolyte compounds can be divided into three major chemical classes: i) sugar and polyols, such as sorbitol and inositols, ii) free amino acids and derivatives, such as taurine and glutamate, and iii) methylamine, such as glycerophosphorylcholine and betaine. Here, we found increased levels of osmoregulators belonging to all of the above mentioned classes in cells of neuronal origin exposed to the pro-inflammatoy cytokine, namely Myo, Scy, Tau and GPC.
In addition to regulating the osmotic balance in neurons, these metabolites play important role in neurotransmission and in maintaning membrane integrity and turnover. Tau is among the most abundant amino acids in the CNS where serves as a major inhibitory neurotransmitter (Su et al. 2014) and a stabilizer of cell membrane by modulating phosphorylation of membrane proteins (Tang et al. 1997 ) and by preventing lipid peroxidation . Inositols (Myo and Scy are the most abundant in the brain) in neurons serve as intermediates in the metabolism of membranes and in the synthesis of second messengers (i.e phosphatidylinositol) (Fisher et al. 2002) . GPC is generated during the breakdown of membrane phospholipids. Changes in the synthesis, breakdown or density of cell membranes have been associated with increases in the 1 H-MRS GPC and Cho signals (Maddock and Buonocore 2012) . It is not surprising that cerebral alteration in the levels of such metabolites has been suggested to be involved in the development of neurodegenerative (Bitsch et al. 1999; Dedeoglu et al. 2004; Chang et al. 2013; Lopes et al. 2013; Ma et al. 2012; Perry et al. 1975; Yang et al. 2011) and psychiatric (Chang et al. 2013; Chen et al. 2009; Forton et al. 2008; Hemanth Kumar et al. 2012) disorders.
In comparison with MRS on humans, the use of HR-MAS NMR in cells allow us to identify in a selected cellular type (neuron-like cell) an higher number of metabolites and to evaluate IFN-α2-induced changes in their levels. Moreover, we were able to measure selected metabolites both in live cells and in their conditioned media thus obtaining information about cellular accumulation and release of metabolites, nutrients utilization from media, and correspondence between cellular and conditioned media metabolic profile. Indeed, whereas only the levels of lactate change both in cells and media, we found that IFN-α2 increases metabolic activity in neuron-like cells, with accumulation of specific metabolites, and, in parallel induces accumulation of metabolic waste products in the conditioned media. Moreover, KEGG pathway analysis also demonstrated that metabolites whose levels are changed in cells and/ or media following IFN-α are involved in the same pathway (i.e. biosynthesis of secondary messengers). Finally, our findings highlight the importance of identifying the compartment (extracellular vs intracellular) in which changes occur (i.e. osmolytes accumulation in cells). Such HR-MAS NMR results on live cells may not directly be compared to MRS study on human subjects, however they may strongly support the interpretation of the significance of the later studies.
Even if we demonstrated that IFN-α2 induced effects on cell density are similar in proliferating SH-SY5Y cells and in non-proliferating or differentiated SH-SY5Y cells (Alboni et al. 2013) , other in vitro models of neurons should be used in the future to further explore the significance of our results. Moreover, the same experimental approach can be usefull to evaluate metabolic effects induced by cytokine exposure in other brain cells (i.e. microglia and astrocytes) that may also play a role in mediating IFNs-α aversive effects.
In summary, our data, obtained by HR-MAS NMR technique on cells (without manipulation) and on their conditioned medium, demonstrate that IFN-α2 induces metabolic changes that may be due, and participate, to changes in energy metabolism, membrane stability, cell integrity and functionality. Now, we can only speculate that IFN-α2-induced changes in the SH-SY5Y cells and media metabolic fingerprints may be associated with IFN-α2-induced central side effects. Future in vivo analyses are needed to possibly provide demonstration of a correlative or even a causative role for these metabolites in the development of the syndromes associated to the treatment with this cytokine.
